Announce Date | 05/09/2025 |
EPS Normalized Actual | $0.716 (Beat by $0.036) |
EPS GAAP Actual | $0.716 (Beat by $0.036) |
Revenue Actual | $18.502B |
Revenue Surprise | Beat by $18502M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.67174 |
EPS GAAP Estimate | $0.67174 |
Revenue Estimate | $8.319122037B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.05532 | 11.03 | 3.16413 | 4.81925 | 1 |
Dec 2028 | 3.8765 | 11.54 | 3.56881 | 4.07206 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.802 | 1.802 | 18.502B | 40.73% | 18502M |
FQ4 2024 (Dec 2024) | -2.18 | -2.18 | 16.279B | 30.6% | 16279M |
FQ3 2024 (Sep 2024) | 0.97 | 0.97 | 14.882B | 33.85% | 14882M |
FQ2 2024 (Jun 2024) | 0.86 | 0.86 | 11.336B | 7.97% | 11336M |
FQ1 2024 (Mar 2024) | 0.67 | 0.67 | 10.966B | -10.11% | 10966M |
FQ4 2023 (Dec 2023) | 0 | 0 | 11.298B | -18.82% | 11298M |
FQ3 2023 (Sep 2023) | 0.26 | 0.26 | 9.844B | -17.56% | 9844M |
FQ2 2023 (Jun 2023) | 0.91 | 0.91 | 10.432B | -26.68% | 10432M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.67174
Consensus Revenue Estimates
8.319122037B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.85012 | -- | 0.85012 | 0.85012 | 2 |
FQ3 2027 (Sep 2027) | 0.70369 | -- | 0.70369 | 0.70369 | 2 |
FQ2 2027 (Jun 2027) | 0.74281 | -- | 0.74281 | 0.74281 | 2 |
FQ1 2027 (Mar 2027) | 0.96799 | -- | 0.96799 | 0.96799 | 2 |
FQ4 2026 (Oct 2026) | 0.7557 | -- | 0.61066 | 0.90119 | 3 |
FQ3 2026 (Jul 2026) | 0.75696 | -- | 0.61168 | 0.90269 | 4 |
FQ2 2026 (Jun 2026) | 0.69551 | -- | 0.61096 | 0.79435 | 4 |
FQ1 2026 (Mar 2026) | 0.83984 | -114.56 | 0.73774 | 0.9592 | 5 |
FQ4 2025 (Oct 2025) | 0.64533 | 437.81 | 0.52147 | 0.76957 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 10.73B | -- | 10.73B | 10.73B | 0 |
FQ3 2027 (Sep 2027) | 10.77B | -- | 10.77B | 10.77B | 0 |
FQ2 2027 (Jun 2027) | 10.81B | -- | 10.81B | 10.81B | 0 |
FQ1 2027 (Mar 2027) | 10.86B | -- | 10.86B | 10.86B | 0 |
FQ4 2026 (Oct 2026) | 5.71B | -- | 4.86B | 6.55B | 1 |
FQ3 2026 (Jul 2026) | 5.71B | -- | 4.87B | 6.56B | 1 |
FQ2 2026 (Jun 2026) | 39.54B | -- | 35.85B | 43.87B | 1 |
FQ1 2026 (Mar 2026) | 36.72B | 49.61 | 33.28B | 40.73B | 1 |
FQ4 2025 (Oct 2025) | 8.99B | -81.15 | 7.66B | 10.32B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.802 | 1.802 | 100% | |
FQ4 2024 (Dec 2024) | -2.18 | -2.18 | 100% | |
FQ3 2024 (Sep 2024) | 0.97 | 0.97 | 100% | |
FQ2 2024 (Jun 2024) | 0.86 | 0.86 | 100% | |
FQ1 2024 (Mar 2024) | 0.67 | 0.67 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 0.26 | 0.26 | 100% | |
FQ2 2023 (Jun 2023) | 0.91 | 0.91 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $18.5B | $18502M | 100% |
FQ4 2024 (Dec 2024) | $0B | $16.28B | $16279M | 100% |
FQ3 2024 (Sep 2024) | $0B | $14.88B | $14882M | 100% |
FQ2 2024 (Jun 2024) | $0B | $11.34B | $11336M | 100% |
FQ1 2024 (Mar 2024) | $0B | $10.97B | $10966M | 100% |
FQ4 2023 (Dec 2023) | $0B | $11.3B | $11298M | 100% |
FQ3 2023 (Sep 2023) | $0B | $9.84B | $9844M | 100% |
FQ2 2023 (Jun 2023) | $0B | $10.43B | $10432M | 100% |